Abstract
In Japan, oncogene panel testing is covered by public insurance since June 2019, and it is now mandatory to explain to the patients the results of testing, after interpretation by an Expert Panel (EP) at cancer genomic medicine hospitals. Therefore, the work burden of interpreting genomic data and proposing treatment based on the results is very heavy on clinicians, making an automated annotation system desirable.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
